Formulation and Evaluation of HPMC Phthalate Succinate-based Tablets of Tolvaptan: In vitro Evaluation

ABSTRACT

Aim: This study aimed to evaluate the performance of novel Hydroxy Propyl Methyl Cellulose Phthalate Succinate polymers (HPMCPS) as alternatives to Hydroxypropyl Methylcellulose Acetate Succinate (HPMCAS) and other polymers. Background: Tolvaptan, classified as a Biopharmaceutics Classification System (BCS) Class IV molecule, exhibits limited solubility and permeability, posing challenges for its formulation. Otsuka Pharmaceuticals addressed this by developing and patenting an amorphous solid dispersion using Hydroxypropyl Cellulose (HPC) as a carrier. In this study, a novel polymer, HPMCPS, was investigated with Tolvaptan as the model drug. Its in vitro performance was systematically compared to established polymers, including HPMCAS, to evaluate its potential as an alternative in enhancing drug solubility and delivery. Materials and Methods: Tolvaptan solid dispersions were prepared with Polyvinylpyrrolidone (PVP), HPC, Hydroxypropyl Methylcellulose (HPMC), HPMC succinate, HPMC phthalate, HPMCAS, and HPMCPS at the same drug-to-polymer ratio using the spray drying technique. Results and Conclusion: Tolvaptan and polymer Spray-Dried Solid Dispersions (SSD) were characterized by FTIR, DSC, SEM, and PXRD. Tablet formulations incorporating these SSDs were evaluated through in vitro dissolution and permeation studies. The shifting of peaks and reduction in peak intensities in FTIR spectroscopy indicated hydrogen bond interactions between the functional groups of the drug and the polymer. DSC studies showed higher glass transition temperatures and stability of SSDs. X-ray diffraction studies confirmed no evidence of crystalline form for all SSDs at the same polymer concentration, except for PVP 30, where some crystalline tolvaptan was observed, which in turn affected dissolution and release. Tolvaptan tablets prepared with novel polymer(s) (HPMCPS) solid dispersion demonstrated either the same or slightly faster dissolution and in vitro permeation behavior compared to the brand Tolvaptan tablets (Jinarc) and tablets prepared with HPC solid dispersion.

KEYWORDS

• Dissolution Enhancement
• Alternate Polymer
• Solid Dispersion
• Solvent Evaporation
• Method
• Spray Drying
• HPMCAS

Showing references and in-text citations exactly as published.

• DOI10.5530/ijper.20262449Copy

RELATED ARTICLES

Matched on section and article type within this issue of IJPER.

• Article · VOLUME 60, ISSUE 3SDevelopment and evaluation of Dry Powder Inhalation Formulation of Remdesivir Nanosuspension by Spray Drying TechniqueArshad Shaikh, Mukesh Pandurang Ratnaparkhi, Sayali Vilas Jadhav, Shailendra Salvankar · pp. s1–s9Original ArticleSame type: Article
• Article · VOLUME 60, ISSUE 3SOptimized Green Synthesis Approaches of Phenytoin Using Divalent Sulfate Salts and Chromatographic Purity Assessment via A Novel RP-HPLC MethodArka Chakraborty, Rajarshi Nath, Biplab Debnath, Arijit Das, Anindya Bose, Shambo Panda · pp. s1–s8Original ArticleSame type: Article
• Article · VOLUME 60, ISSUE 3SFormulation and Evaluation of Beclomethasone Dipropionate Loaded Niosomal Gel for Topical UseMahesh Birajdar, Rohit Sarda, Shradha Tiwari, Dnyaneshwari Jadhav, Sameep Sonvane, Prakash Shivnechari, Kranti Satpute · pp. s918–s928Original ArticleSame type: Article
• Article · VOLUME 60, ISSUE 3SDesign and Development of Self-Micro Emulsifying Drug Delivery Systems of Rifaximin Using 32 Factorial DesignOnkar Vilas Jadhav, Twarita Dilip Deshpande, Udaykumar Baburao Bolmal, Anuj Jagannath Shinde, Shital Vishwas Patil · pp. s929–s943Original ArticleSame type: Article